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Introduction {#sec005}
============

Primary care is increasingly responsible for the care of patients with long-term conditions, and improving the quality of their care is a major policy priority \[[@pone.0135947.ref001]\]. Patient safety is an essential component of high quality of care. Patient safety is defined as the 'avoidance, prevention, and amelioration of adverse outcomes or injuries stemming from the processes of health care'\[[@pone.0135947.ref002]\]. Patient safety incidents are viewed as 'any unintended events or hazardous conditions resulting from the process of care, rather than due to the patient\'s underlying disease, that led or could have led to unintended health consequences for the patient or health care processes linked to safety outcomes'\[[@pone.0135947.ref003]\]. Patient safety incidents can occur during access to care, clinical delivery (i.e. adverse drug events, prescription errors, diagnostic error), or in the organisation of care (i.e. inter-professional communication or co-ordination failures) \[[@pone.0135947.ref003], [@pone.0135947.ref004]\]. Safety incidents often refer to incidents that involve some form of harm for the patient. Safety incidents however can also include 'precursors', which have the potential to lead to harm if not prevented or managed appropriately \[[@pone.0135947.ref003]\]. For instance, adverse drug reactions/poisoning resulting from taking an incorrect drug or dose are viewed as 'active safety incidents', whereas errors in prescribing drugs which have the potential to lead to adverse drug reactions are considered 'precursors of safety incidents'.

Although there have been significant improvements in delivery of care for long-term conditions \[[@pone.0135947.ref005]\], many quality improvement activities \[[@pone.0135947.ref006]\], clinical guidelines \[[@pone.0135947.ref007], [@pone.0135947.ref008]\] and innovations in service delivery \[[@pone.0135947.ref009]\] have focussed on the needs of patients with single long-term conditions. However, multimorbidity broadly defined as 'the co-existence of two or more chronic conditions, where one is not necessarily more central than the others' \[[@pone.0135947.ref010]\], is increasingly prevalent \[[@pone.0135947.ref011]\], and represents a major part of the workload of primary care \[[@pone.0135947.ref012]\].

Patients with multimorbidity are likely to be at risk from all types of safety incidents, due to a number of reasons. Individual patients with multimorbidity are more likely to have to manage complex medication and other management regimes \[[@pone.0135947.ref013]\], face difficult decisions about self-management and dealing with priorities among conditions and their management \[[@pone.0135947.ref014]\], and may not receive the quality of communication that is required to support them in the context of these demands \[[@pone.0135947.ref015]\]. The frequency and complexity of their interactions with health services may make them more vulnerable to failures of care delivery and co-ordination \[[@pone.0135947.ref016], [@pone.0135947.ref017]\]. Patients with multimorbidity are also likely to demonstrate characteristics which will further increase their vulnerability to safety incidents, such as poor health \[[@pone.0135947.ref002]\], advanced age \[[@pone.0135947.ref018]\], cognitive impairment \[[@pone.0135947.ref019]\], limited health literacy \[[@pone.0135947.ref020]\], and levels of depression and anxiety \[[@pone.0135947.ref021], [@pone.0135947.ref022]\]. Particularly, patients with multimorbidity with concurrent mental health conditions such as depression (referred to as 'mental-physical' multimorbidity hereafter) report lower quality of care compared with patients with physical long-term conditions only \[[@pone.0135947.ref023], [@pone.0135947.ref024]\]. It is likely that the time constrains and the tendency to prioritise the management of physical long-term conditions in primary care, adversely affects the quality of care delivered to patients with mental-physical multimorbidity \[[@pone.0135947.ref025]--[@pone.0135947.ref027]\]. Moreover, patients with mental-physical multimorbidity may have reduced capacity or motivation to self-care \[[@pone.0135947.ref028]\], receive less integrated care, and face more care co-ordination failures due to the complexity of their care needs \[[@pone.0135947.ref026], [@pone.0135947.ref029]\]. Therefore, patients with mental-physical multimorbidity might comprise a distinct, high-risk sub-group for safety incidents within the group of patients with multimorbidity.

Even though patients with multimorbidity may generally be at higher risk of safety incidents, there may be occasions where they face lower risk. Some measures of quality of care are higher in patients with multimorbidity \[[@pone.0135947.ref030]\]. This may reflect greater numbers of clinical encounters in such patients (with greater monitoring and opportunities to identify safety risks), or the development of self-management expertise in patients familiar with managing multiple, complex problems \[[@pone.0135947.ref031]\]. Our own research demonstrated that patient experience of aspects of care for long-term conditions did not differ markedly between patients with single or multiple conditions \[[@pone.0135947.ref032]\].

It is currently uncertain whether there are any specific groups of patients with multimorbidity who are more susceptible to patient safety incidents and whether there are any particular types of patient safety incidents that are more prevalent in patients with multimorbidity. This makes it difficult to design and embed interventions within existing care models to improve patient safety among people with multimorbidity.

We undertook a systematic review and evidence synthesis on multimorbidity and patient safety. This review sought to answer two research questions: Are patients with multimorbidity more vulnerable to patient safety incidents?Does the relationship between multimorbidity and patient safety vary across different types of multimorbidity and different types of patient safety outcomes?

Methods {#sec006}
=======

The methods and results for this review are reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines The completed PRISMA checklist is included in [S1 PRISMA Checklist](#pone.0135947.s001){ref-type="supplementary-material"}. \[[@pone.0135947.ref033]\].

Search strategy {#sec007}
---------------

The following electronic bibliographic databases were searched for eligible papers: Medline, Embase and Cinahl (from inception until December 2013 and then updated to May 2015). Our search strategy included combinations of three key blocks of terms (*multimorbidity/ comorbidity*, *patient safety* and *primary care*) using a combination of Medical Subject Headings and text-words. (See the Medline search strategy in [S1 Appendix](#pone.0135947.s002){ref-type="supplementary-material"}. Database searches were supplemented by hand searches of reference lists of included papers. No previous reviews have been identified in the area. We excluded studies in languages other than English and studies in the grey literature.

Eligibility criteria {#sec008}
--------------------

Studies were eligible for inclusion in this review if they met the following criteria: Population: Adult patients (18 years or above) with two or more physical long-term conditions, or combinations of physical and mental long-term conditions. We included in the review patients with any physical long-term condition such as diabetes, chronic obstructive pulmonary disease, arthritis and hypertension. Mental long-term conditions mainly comprised mental health conditions such as depressive disorders and psychoses. We excluded studies which were solely based on patients with two or more mental health conditions (i.e. depression comorbid with schizophrenia) without concurrent physical long-term conditions. We also excluded studies based on patients with combinations of mental and substance use/alcohol use conditions.Design: Quantitative research design (case control, cross-sectional, retrospective or prospective cohort, or controlled trial).Setting: Primary care, the interface between primary and specialty care (e.g., emergency department), and studies in general population samples. We excluded studies conducted exclusively in specialist settings.Multimorbidity measure: We included studies which reported: A measure of physical multimorbidity (based on simple count of long-term conditions or more complex multimorbidity indices) or combinations of two or more specific physical long-term conditions (such as comorbid diabetes with hypertension).A measure of mental-physical multimorbidity, defined as combinations of physical and mental long-term conditions (such as diabetes and depression). Only studies which made an explicit distinction between physical and mental comorbidities were included in the "mental-physical multimorbidity" category. Studies which were not explicit about the inclusion of mental long-term conditions in the definition of multimorbidity were not included in this category.Patient safety incident: After reviewing the theoretical and empirical literature on patient safety, and after consultation with the expert patient safety researchers in the team, we distinguished two types of safety measures: Active patient safety incidents i.e. measures of adverse outcomes or injuries stemming from the processes of health care \[[@pone.0135947.ref002]\], such as *adverse drug events* (resulting from wrong dose, drug-drug interactions) and *other adverse events* such as intervention complications, infections and care failures (i.e. pressure ulcers).Precursors of patient safety incidents i.e. factors potentially leading to adverse outcomes or injuries \[[@pone.0135947.ref002]\]. This included *prescription errors* such as inappropriate prescribing, over or under utilisation of drugs, *medication non-adherence*, *diagnostic errors* such as wrong or delayed diagnosis and *poor quality of care* resulting from failure to adhere to established guidelines for care provision or from communication and co-ordination failures.Quantitative association between the multimorbidity measure and patient safety outcomes which was amenable to meta-analysis. We sought data that would allow the computation of an effect size (odds ratio) for the association of multimorbidity with patient safety outcomes. We sought data that would allow the computation of an effect size (odds ratio) for the association of multimorbidity with patient safety outcomes. We excluded studies that lacked data to compute an effect size of for the association between multimorbidity and patient safety outcome (i.e. only reported means without standard deviations or p-values).

Study selection {#sec009}
---------------

Study selection was completed in two stages. Initially, the titles and abstracts of the identified studies were screened for eligibility by the first author. A subset of titles and abstracts (20%) were screened independently by a second reviewer (kappa coefficient = 0.78). Next, the full-texts of studies assessed as potentially relevant for the review were retrieved and checked against our inclusion and exclusion criteria. Forty percent of the full-text screening was completed by two researchers working independently. Any disagreements were resolved by discussion. Given the high inter-rater reliability (kappa coefficient = 0.85), the remaining full-text screening was completed by the first author.

Data extraction {#sec010}
---------------

A data extraction form was devised in Microsoft Excel and piloted on five randomly selected studies. We extracted the following descriptive data: country, research design, population, recruitment method, research setting, participant characteristics (number, age, gender, long-term conditions), multimorbidity measure, patient safety outcomes and methodological quality. We also extracted quantitative data on the association between multimorbidity and patent safety. Thirty percent (n = 20 studies) of the data extraction was completed by 2 members of the research team working independently. No substantial disagreements were observed (kappa 0.91 across 2160 data points); the remainder of the data were extracted by one member and checked by a second.

Methodological quality of the studies {#sec011}
-------------------------------------

The vast majority of the studies included in the review were observational studies (cross-sectional and cohort studies). As well as distinguishing these different designs, we also assessed methodological quality using criteria adapted from guidance on the assessment of observational studies \[[@pone.0135947.ref034]\]. Quality criteria were not used to exclude studies in the review. The quality appraisal included three key criteria: Response rate or data capture among eligible patients of 70% or greater at baselineResponse rate or data capture of 70% or greater at follow-up (for prospective studies only)Control for a minimum of 3 important confounding factors in the analysis which comprised a combination of demographic characteristics (age, gender) and clinical characteristics relevant to patient safety incidents (e.g. drug use/polypharmacy, contacts with health professionals and health services, disability levels).

These criteria have been previously used by members of our research group to assess the methodological quality of observational studies \[[@pone.0135947.ref035]\]. Studies were assigned a rating of 1 for each criterion met (maximum rating of 3). Substantial agreement between reviewers regarding methodological quality (kappa 0.89).

Data synthesis {#sec012}
--------------

The primary outcome of this review was the effect of multimorbidity on patient safety outcomes ('active patient safety incidents' and 'precursors of safety incidents'). From the available data we calculated odds ratios (ORs) together with the 95% confidence intervals from each study using the Comprehensive Meta-analysis (CMA) software \[[@pone.0135947.ref036]\]. ORs were typically computed from dichotomous data (number/rates of safety incidents), but continuous data (i.e. means) were also converted to ORs in CMA. CMA allows computation of ORs from several input parameters (dichotomous, continuous or both data types) including all eight methods proposed by the Cochrane Handbook \[[@pone.0135947.ref037]\], as well as additional methods proposed in the literature \[[@pone.0135947.ref038]\]. We chose ORs to pool the results because this was the most commonly reported estimate for effect in the individual studies, and because ORs are considered more appropriate for use across different research designs (including cross-sectional and case-control designs) compared with other estimates such as relative risks \[[@pone.0135947.ref039]\]. In this study, OR \>1 indicates that multimorbidity is associated with increased risk for patient safety incidents, whereas OR \<1 indicates that multimorbidity is associated with a lower risk for patient safety incidents. Across studies reporting adjusted and unadjusted models, we selected the model in which effect sizes were adjusted for potentially confounding variables to the maximum extent.

The I^2^-statistic was used to assess heterogeneity among studies. Conventionally, I^2^ values of 25%, 50%, and 75% indicate low, moderate, and high heterogeneity \[[@pone.0135947.ref040]\]. Subgroup analyses were performed to explore potential sources of heterogeneity of the relationship between multimorbidity and patient safety incidents (e.g. the effects of types of multimorbidity). In line with the Cochrane Handbook \[[@pone.0135947.ref041]\], we compared subgroups informally by comparing the magnitudes of effect within each. A sensitivity analysis was undertaken to evaluate the stability of the results after only the studies with higher ratings (as indicated by ratings on the 3 quality assessment criteria) were retained in the analysis. The possibility of publication bias was examined by inspecting the symmetry of the funnel plot and using Egger's test \[[@pone.0135947.ref042]\].

In accordance with recommendations \[[@pone.0135947.ref043]\], across studies reporting multiple measures of the same safety incident (e.g. different measures of poor quality) or the same type of multimorbidity (e.g. effects of multiple types of physical comorbidities on adverse drug events) weighted average ORs were computed to ensure that each study contributed only one effect measure of each outcome to the meta-analysis. Where studies reported data on different types of safety incidents such as poor quality of care and prescription error (N = 3), or different types of multimorbidity including physical multimorbidity and mental-physical multimorbidity (N = 8), we also computed the mean of the comparisons for each study, and entered this aggregate score in the pooled analysis. However, in analyses in which there was no overlap of these comparisons (subgroup analyses examining the distinct effects of types of safety incidents or types of multimorbidity), each comparison was treated as a separate unit of analysis.

All meta-analyses were performed in STATA (version 12) using the metan command \[[@pone.0135947.ref044]\]. Funnel plots were constructed using the metafunnel command \[[@pone.0135947.ref045]\], and the Egger test was computed using the metabias command \[[@pone.0135947.ref046]\]. Random effects models were applied to calculate pooled ORs because of anticipated heterogeneity.

Results {#sec013}
=======

Overall, 7,630 titles and abstracts were screened for eligibility. Following screening, 75 studies (providing 86 relevant comparisons) met the inclusion criteria ([Fig 1](#pone.0135947.g001){ref-type="fig"}) \[[@pone.0135947.ref023], [@pone.0135947.ref024], [@pone.0135947.ref047]--[@pone.0135947.ref119]\]

![Flowchart of studies included in the review.](pone.0135947.g001){#pone.0135947.g001}

Characteristics of studies and populations {#sec014}
------------------------------------------

Key descriptive data for the studies included in the review are presented in [Table 1](#pone.0135947.t001){ref-type="table"}. Details of data extracted from individual studies (study, population and outcomes) are provided in [Table 2](#pone.0135947.t002){ref-type="table"}. Additional information about the population, outcomes and quality assessment is presented in [S1 Table](#pone.0135947.s003){ref-type="supplementary-material"}. Studies included patients with a wide range of ages, with the average around 60, and approximately equal gender representation. Most studies were based in primary care, and most common designs were retrospective cohorts and cross-sectional studies (see [Table 2](#pone.0135947.t002){ref-type="table"} for more details).

10.1371/journal.pone.0135947.t001

###### Basic study descriptive data.

![](pone.0135947.t001){#pone.0135947.t001g}

  Category                                   Characteristics              N = 75 studies
  ------------------------------------------ ---------------------------- -----------------------------
  **Study and population**                   Sample size (range)          3,791,196 (40 to 1,265,434)
  Mean Age (range)                           59 (38--80)                  
  \% Male                                    52%                          
  **Country**                                                             
  US                                         39 (52%)                     
  European                                   24 (32%)                     
  Other                                      12 (16%)                     
  **Quality**                                **Research design**          
  Cross-sectional                            31 (41%)                     
  Prospective cohort                         8 (11%)                      
  Retrospective cohort                       32 (43%)                     
  Trial (randomized/non randomized)          1 (1%)                       
  Case control                               3 (4%)                       
  **Methodological quality**                                              
  Response rate at baseline- 70% and over    29 (39%)                     
  Response rate at follow-up -70% and over   2 (3%)                       
  Control for confounding factors            47 (63%)                     
  **Outcomes**                               **Patient safety outcome**   **N = 86 comparisons**
  Active safety incidents                    26 (30%)                     
  Adverse drug events                        15 (17%)                     
  Other adverse events                       11 (13%)                     
  Precursors of safety incidents             60 (70%)                     
  Quality of care                            30 (35%)                     
  Prescription error                         19 (22%)                     
  Medication non-adherence                   6 (7%)                       
  Diagnostic error                           5 (6%)                       
  **Multimorbidity**                         **N = 86 comparisons**       
  Mental-physical multimorbidity             20 (23%)                     
  Physical multimorbidity                    66 (77%)                     

10.1371/journal.pone.0135947.t002

###### Characteristics of studies, populations and outcomes included in the review.

![](pone.0135947.t002){#pone.0135947.t002g}

  Study ID                    Country       Setting                                                                      Research design                                N           Men (%)   Mean age (SD; Range)                 Multimorbidity                                            Patient safety incident                          Overall quality
  --------------------------- ------------- ---------------------------------------------------------------------------- ---------------------------------------------- ----------- --------- ------------------------------------ --------------------------------------------------------- ------------------------------------------------ -----------------
  Bae et al. 2008             US            General population                                                           Cross-sectional                                1,700       41%       18 years over                        Physical multimorbidity                                   Poor quality of care                             1
  Barham et al. 2009          US            Primary care practices                                                       Retrospective                                  1,701       41%       Range = 21--87                       Physical multimorbidity                                   Poor quality of care                             1
  Beer et al. 2010            Australia     Primary care practices                                                       Prospective                                    4,260       100%      M = 77; SD = 3.6; Range = 65--83     Physical multimorbidity                                   Prescription errors                              0
  Berger et al. 2009          Germany       Primary care practices                                                       Retrospective                                  975         28%       M = 75.0; SD = 7.3; 65 and over      Mental-physical multimorbidity                            Prescription errors                              0
  Bertomeu et al. 2009        Spain         Primary care and outpatient practices                                        Cross-sectional                                2,767       72%       M = 67.5; SD = 11.4                  Physical multimorbidity                                   Prescription errors                              2
  Blais et al. 2013           Canada        Charts of patients                                                           Retrospective                                  1,200       n/a       M = 71.52                            Physical multimorbidity                                   Other adverse events                             2
  Blecker et al. 2010         US            Medicaid claims data                                                         Retrospective                                  1,801       31%       M = 58.7; SD = 9.4; Range = 21--62   Mental-physical multimorbidity                            Prescription errors; Poor quality of care        1
  Bont et al. 2007            Netherlands   Primary care practices                                                       Retrospective                                  2,643       45%       M = 75; SD = 7.0; Range = 65--101    Physical multimorbidity                                   Prescription errors                              1
  Buja et al. 2014            Italy         Primary care practices                                                       Retrospective                                  105,987     56%       16 and over                          Physical multimorbidity                                   Poor quality of care                             1
  Cahir et al. 2013           Ireland       Primary care practices                                                       Retrospective                                  931         47%       M = 78;SD = 5.4; Range: 70--98       Physical multimorbidity                                   Adverse drug events                              2
  Calderon et al. 2012        Spain         Primary care practices                                                       Retrospective                                  79,089      44%       18 and over                          Physical multimorbidity                                   Adverse drug events                              2
  Calvert et al. 2009         UK            Primary care practices                                                       Retrospective                                  9,311       49%       M = 80.1; Range = 72.5--86.0         Physical multimorbidity                                   Prescription errors                              2
  Chen et al. 2011            Taiwan        Emergency department                                                         Prospective                                    452         n/r       18 and over                          Physical multimorbidity                                   Adverse drug events                              2
  Classen et al. 2007         US            General population                                                           Retrospective                                  191         40%       Range = 60 over                      Physical multimorbidity                                   Adverse drug events                              1
  Dalton et al. 2011          UK            Primary care practices                                                       Cross-sectional                                3,294       56%       M = 61; Range = 17 over              Physical multimorbidity                                   Poor quality of care                             2
  Davis et al. 2008           UK            General population                                                           Retrospective                                  955         45%       M = 77.0; SD = 10.0                  Physical multimorbidity                                   Prescription errors                              0
  Desai et al. 2005           US            Veterans Affairs health services                                             Cross-sectional                                15,580      79%       M = 61.3; SD = 13.9                  Physical multimorbidity                                   Diagnostic errors                                1
  Desai et al. 2006           US            Veterans Affairs health services                                             Cross-sectional                                21,489      83%       n/r                                  Physical multimorbidity                                   Diagnostic errors                                1
  Drivenes et al. 2014        Norway        Primary Care Practicees                                                      Cross-sectional                                376         46%       Median = 62                          Physical multimorbidity                                   Prescription errors                              0
  Druss et al. 2012           US            Medicaid claims data                                                         Cross-sectional                                113,505     84%       n/r                                  Mental-physical multimorbidity                            Poor quality of care                             1
  Eguale et al. 2012          Canada        Primary care practices                                                       Cross-sectional                                50,823      n/r       n/r                                  Physical multimorbidity                                   Prescription errors                              1
  Fernandez et al. 2015       Spain         Primary care practices                                                       Cross-sectional                                1,214       79%       M = 66.4, SD = 9.7; R = 40 over      Physical multimorbidity                                   Diagnostic errors                                2
  Field et al. 2004           US            Primary care practices                                                       Case-control                                   1,598       41%       M = 75.2; R = 65 over                Physical multimorbidity                                   Adverse drug events                              0
  Frigola et al. 2013         Netherlands   Primary care practices                                                       Retrospective                                  7,173       41%       M = 76.3; SD = 10.7                  Physical multimorbidity                                   Prescription errors                              0
  Ghembaza et al. 2014        Algeria       Primary care practices                                                       Cross-sectional                                453         24%       M = 62, SD = 1.16                    Physical multimorbidity                                   Medication non-adherence                         1
  Goldberg et al. 2007        US            Primary care practices                                                       Cross-sectional                                300         59%       n/r                                  Mental-physical multimorbidity                            Poor quality of care                             2
  Harman et al. 2004          US            General population                                                           Retrospective                                  498         n/r       65 and over                          Physical multimorbidity                                   Poor quality of care                             1
  Hayes et al. 2014           Canada        Primary care practices                                                       Retrospective                                  187         62%       M = 44; Range = 35--55               Physical multimorbidity                                   Other adverse event                              1
  Hesse 2015                  UK            Data from trials registered in Virtual International Stroke Trials Archive   Retrospective                                  5775        54%       M = 69.3, SD = 12.3                  Physical multimorbidity                                   Other adverse events                             1
  Higashi et al. 2007         US            General population                                                           Retrospective                                  7,680       48%       n/r                                  Physical multimorbidity                                   Poor quality of care                             0
  Ho et al. 2006              US            Primary care practices                                                       Retrospective                                  11,532      51%       Range = 18 over                      Physical multimorbidity                                   Medication non-adherence                         0
  Kanner et al. 2012          US            Primary care practices                                                       Cross-sectional                                188         32%       M = 39; SD = 11.7                    Mental-physical multimorbidity                            Adverse drug events                              1
  Katerndahl et al. 2012      US            Primary care practices                                                       Cross-sectional                                102         30%       M = 56.8; SD = 10.6                  Mental-physical multimorbidity                            Medication non-adherence; Poor quality of care   1
  Ko et al. 2013              US            General population                                                           Cross-sectional                                40          60%       M = 58; SD = 13; Range: 24--88       Physical multimorbidity                                   Poor quality of care                             0
  Kontopantelis et al. 2013   UK            Primary care practices                                                       Prospective                                    23,920      69%       M = 62.9; 18 and over                Physical multimorbidity                                   Poor quality of care                             1
  Krein et al. 2006           US            Veterans Affairs health services registries                                  Case control                                   36,546      97%       M = 58; SD = 12                      Mental-physical multimorbidity                            Poor quality of care                             0
  Lagomasino et al. 2005      US            Primary care practices                                                       Cross-sectional                                1,175       30%       M = 43.9; SD = 15.3; 18 and over     Physical multimorbidity                                   Prescription errors                              2
  Lin et al. 2013             US            Medicare claims records                                                      Cross-sectional                                19,863      70%       65 and over                          Physical multimorbidity                                   Other adverse events                             1
  Lu et al. 2011              US            General population                                                           Cross-sectional                                11,910      40%       M = 51.1; SD = 16.3                  Physical multimorbidity                                   Prescription errors                              1
  Mand et al. 2014            Germany       Primary care practices                                                       Retrospective                                  24,619      63%       M = 75.7, SD = 7.8 Range = 65--107   Mental-physical multimorbidity/Physical multimorbidity    Adverse drug events                              1
  Marcum et al. 2012          US            Veterans Affairs Medical Centres                                             Retrospective                                  678         99%       M = 76.4; 65 and over                Physical multimorbidity                                   Adverse drug events                              0
  McGovern et al. 2013        UK            Primary Care                                                                 Retrospective                                  35,502      54%       M = 63.6; SD = 14.3                  Physical multimorbidity                                   Other adverse events                             1
  Mensah et al. 2007          UK            Primary care practices                                                       Cross-sectional                                515         50%       M = 49, R = 78                       Mental-physical multimorbidity                            Adverse drug events                              0
  Mikuls et al. 2005          US            Primary care practices                                                       Retrospective                                  708         72%       M = 61; SD = 15                      Physical multimorbidity                                   Poor quality of care                             1
  Min et al. 2014             US            Primary care practices                                                       Cross-sectional                                644         67%       M = 80; over 70                      Physical multimorbidity                                   Poor quality of care                             2
  Mira et al. 2014            Spain         Primary care practices                                                       Cross-sectional                                265         53%       M = 72.5; SD = 5.5; over 65          Physical multimorbidity                                   Adverse drug events                              0
  Nasser et al. 2009          Bahrain       Primary care practices                                                       Cross-sectional                                808         39%       20 and over                          Mental-physical multimorbidity                            Other adverse events                             0
  Nuyen et al. 2005           Netherlands   Primary care practices                                                       Cross-sectional                                191         28%       M = 45.4; SD = 14.1                  Physical multimorbidity                                   Diagnostic errors                                2
  Obreli-Neto et al. 2012     Brazil        Primary care practices                                                       Prospective                                    433         20%       M = 67; Range = 64--67               Physical multimorbidity                                   Adverse drug events                              2
  Parchman et al. 2005        US            Veterans Affairs Medical Centre                                              Cross-sectional                                420         82%       n/r                                  Physical multimorbidity                                   Adverse drug events                              1
  Pawaskar et al. 2008        US            Primary care practices                                                       Cross-sectional                                5,487       40%       18 and over                          Mental-physical multimorbidity; Physical multimorbidity   Prescription errors                              1
  Petersen et al. 2009        US            Veterans Affairs facilities                                                  Prospective                                    141,609     n/r       M = 63.4; SD = 12.4                  Physical multimorbidity                                   Poor quality of care                             1
  Pugh et al. 2005            US            Veterans Affairs outpatient facilities                                       Retrospective                                  1,265,434   98%       M = 73.5; SD = 5.6; 66 and over      Mental-physical multimorbidity; Physical multimorbidity   Prescription errors                              1
  Pugh, et al. 2010           US            Veterans Affairs and Medicare databases                                      Retrospective                                  9,682       98%       66 and over                          Mental-physical multimorbidity; Physical multimorbidity   Adverse drug events                              1
  Reichard et al. 2012        US            Kansas Medicaid programme                                                    Retrospective                                  9,532       35%       M = 53.5; 18 and over                Physical multimorbidity                                   Poor quality of care                             1
  Rigler 2004 et al.          US            Medicaid claims data                                                         Retrospective                                  3,185       23%       65 and over                          Physical multimorbidity                                   Prescription errors                              2
  Ruigomez et al. 2007        UK            UK General Practice Research Database                                        Prospective                                    906         48%       Range = 40--89                       Physical multimorbidity                                   Other adverse events                             2
  Rupert, 2010 et al.         US            Primary care                                                                 Cross-sectional                                295         55%       M = 62; SD = 14                      Mental-physical multimorbidity; Physical multimorbidity   Poor quality of care                             0
  Schnitzer et al. 2012       Germany       Complains forwarded to Patient Commissioner in Germany                       Cross-sectional                                13,505      48%       n/r                                  Physical multimorbidity                                   Poor quality of care; Prescription errors        1
  Shireman et al. 2010        US            Medicaid claims data                                                         Retrospective                                  666         50%       M = 43.1; SD = 11.9                  Physical multimorbidity                                   Poor quality of care                             1
  Simeone et al. 2012         US            Medical claims to MarketScan commercial database                             Case-control                                   11,372      54%       M = 54.5; SD = 7.9                   Physical multimorbidity                                   Other adverse events                             0
  Simpson et al. 2007         US            Primary care practices                                                       Cross-sectional                                2,198       38%       n/r                                  Physical multimorbidity                                   Poor quality of care                             1
  Sloane et al. 2004          US            Primary care practices                                                       Cross-sectional                                2,014       24%       65 and over                          Physical multimorbidity                                   Prescription errors                              2
  Streit et al. 2014          Sweden        Primary care practices                                                       Retrospective                                  1,002       56%       M = 65; 50 to 80                     Physical multimorbidity                                   Poor quality of care                             1
  Thorpe et al. 2012          US            Centres for Medicare and Medicaid Services                                   Retrospective                                  288,805     38.20%    65 and over                          Mental-physical multimorbidity; Physical multimorbidity   Poor quality of care                             0
  Tomio et al. 2010           Japan         National Health Insurance claims data                                        Retrospective                                  636         49%       M = 72.7; SD = 9.2                   Mental-physical multimorbidity; Physical multimorbidity   Poor quality of care                             1
  Tsang et al. 2013           UK            General Practice Research Database                                           Cross-sectional                                74,763      48%       n/r                                  Physical multimorbidity                                   Other adverse events                             2
  van Dijk et al. 2007        Netherlands   Dutch general practice registration database                                 Retrospective                                  21,524      n/r       n/r                                  Physical multimorbidity                                   Medication non-adherence                         2
  Weisman et al. 2007         US            Primary care practices                                                       Controlled, randomized, double-blinded trial   535         78%       M = 59.3, Range = 23--85             Physical multimorbidity                                   Other adverse events                             1
  Whooley et al. 2008         US            Primary care practices                                                       Prospective                                    1,017       41%       M = 63; SD = 12                      Mental-physical multimorbidity                            Medication non-adherence                         1
  Wolff et al. 2002           US            Medicare beneficiaries database                                              Cross-sectional                                1,217,103   39%       M = 75.4; 65 and over                Physical multimorbidity                                   Other adverse events                             1
  Wong et al. 2015            Canada        National Ambulatory Care Reporting System database                           Retrospective                                  56,767      53%       M = 66, SD = 15                      Physical multimorbidity; Mental-physical multimorbidity   Poor quality of care                             1
  Wong et al. 2011            China         Primary care clinics                                                         Retrospective                                  12,875      44%       65 and over                          Physical multimorbidity                                   Medication non-adherence                         1
  Woodard et al. 2012         US            Veterans affairs medical centres                                             Prospective                                    35,872      n/r       M = 58.7                             Physical multimorbidity                                   Poor quality of care                             0
  Zwar et al. 2011            Australia     Primary care practices                                                       Cross-sectional                                445         49%       Range = 40--80                       Physical multimorbidity                                   Diagnostic errors                                0

*Note*: n/r = not reported, M = mean, R = range, SD = standard deviation

Characteristics of multimorbidity measures and patient safety outcomes {#sec015}
----------------------------------------------------------------------

Multimorbidity was assessed using a wide range of methods. Sixty-six comparisons reported a measure of physical multimorbidity based on index tools for multimorbidity such as the Charlson index \[[@pone.0135947.ref120]\], simple counts of diseases or listing specific physical comorbidities among long-term conditions. The remaining comparisons examined the mental-physical comorbidity (n = 20, where mental health condition was mainly depression). Eight studies reported an analysis of both physical multimorbidity and mental-physical multimorbidity.

'Active patient safety incidents' were reported in 26 comparisons and comprised the following outcomes: adverse drug events including drug-drug interactions and drug side effectsadverse non-drug related medical events such as medical complications and adverse medical outcomes associated with care delivery

'Precursors of patient safety incidents' were reported in 60 comparisons and comprised the following outcomes: poor quality of care (non-adherence to guidelines and quality indicators)prescription errors such as over or underuse of drugs or inappropriate prescribingmedication non-adherencediagnostic errors

Methodological quality characteristics {#sec016}
--------------------------------------

In terms of the individual quality criteria, 29 studies reported a response rate of 70% or greater, and 47 studies adjusted for confounders in the analyses. Only 2 of the 8 prospective studies reported response rates at follow-up. Nineteen (25%) studies met at least 2 of the 3 quality criteria whereas only two studies met all three criteria (see Tables [1](#pone.0135947.t001){ref-type="table"} and [2](#pone.0135947.t002){ref-type="table"}).

Meta-analysis: Active safety incidents and multimorbidity {#sec017}
---------------------------------------------------------

The pooled effect indicated that multimorbidity was associated with a significantly increased risk for active safety incidents, but outcomes exhibited high heterogeneity (OR = 1.95, 95% CI = 1.75 to 2.19, I^2^ = 98.5%, p\<0.001- [Fig 2](#pone.0135947.g002){ref-type="fig"}). No studies reported that multimorbidity was related to significantly fewer active safety incidents.

![Main analysis of the association between active safety incidents and multimorbidity.](pone.0135947.g002){#pone.0135947.g002}

The effects of multimorbidity were broadly similar on the two types of active safety incidents: adverse drug events (OR = 2.10, 95% CI = 1.64 to 2.55, I^2^ = 98.7%, p\<0.001) and other adverse events (OR = 1.80, 95% CI = 1.53 to 2.07, I^2^ = 97.8%, p\<0.001---[Fig 3](#pone.0135947.g003){ref-type="fig"}).

![Subgroup analysis of the association between active safety incidents and multimorbidity analysed by different types of active safety incidents.](pone.0135947.g003){#pone.0135947.g003}

Moreover, mental-physical multimorbidity was associated with a higher risk for active safety incidents when compared with physical multimorbidity only (OR = 2.39, 95% CI = 1.40 to 3.38, I^2^ = 99.4%, p\<0.001 and OR = 1.63, 95% CI = 1.45 to 1.80, I^2^ = 96.3%, respectively---[Fig 4](#pone.0135947.g004){ref-type="fig"}).

![Subgroup analysis of the association between active safety incidents and multimorbidity analysed by different types of multimorbidity.](pone.0135947.g004){#pone.0135947.g004}

Meta-analysis: Precursors of safety incidents and multimorbidity {#sec018}
----------------------------------------------------------------

A mixed pattern of findings was observed for precursors of safety incidents. The pooled effect size indicated that multimorbidity was associated with marginally increased risk for precursors of safety incidents, while the heterogeneity was high (OR = 1.16, 95% CI = 1.04 to 1.28, I^2^ = 98.6%, p\<0.001- data not shown).

A notable proportion of the comparisons (n = 25) reported that multimorbidity was significantly associated with a higher risk of precursors of safety incidents, whereas a smaller but considerable proportion of the comparisons (n = 15) reported that multimorbidity was associated with a lower risk of precursors (mainly with quality of care).

There was some evidence that the risk for precursors of safety incidents was moderated by types of multimorbidity. Mental-physical multimorbidity was associated with increased risk for precursors of safety incidents (OR = 1.69, 95% CI = 1.36 to 2.03, I^2^ = 99.0%, p\<0.001- data not shown) whereas no association was found between physical multimorbidity and precursors of safety incidents (OR = 1.02, 95% CI = 0.90 to 1.13, I^2^ = 98.0%, p\<0.001-data not shown). However, heterogeneity remained high, and the results for each subtype of precursors of safety incidents (and the effects of types of multimorbidity on each outcome) are presented separately below.

### Poor quality of care {#sec019}

The pooled effect size indicated no association between poor quality of care and multimorbidity (OR = 1.05, 95% CI = 0.90 to 1.20, I^2^ = 98.2%, p\<0.001---[Fig 5](#pone.0135947.g005){ref-type="fig"}). Heterogeneity was high, with 9 comparisons indicating that multimorbidity was associated with a higher risk for poor quality of care whereas 8 comparisons indicated that people with multimorbidity were less likely to experience poor quality of care.

![Main analysis of the association between poor quality of care and multimorbidity.](pone.0135947.g005){#pone.0135947.g005}

The risk for poor quality of care varied across types of multimorbidity. Mental-physical multimorbidity was associated with poorer quality of care (OR = 1.25, 95% CI = 1.06 to 1.45, I^2^ = 97.3%, p\<0.001- [Fig 6](#pone.0135947.g006){ref-type="fig"}), whereas the effects of physical multimorbidity on quality of care were non-significant (OR = 0.97, 95% CI = 0.78 to 1.16, I^2^ = 97.9%, p\<0.001- [Fig 6](#pone.0135947.g006){ref-type="fig"}).

![Subgroup analysis of the association between poor quality of care and multimorbidity analysed by different types of multimorbidity.](pone.0135947.g006){#pone.0135947.g006}

### Prescription errors {#sec020}

The pooled effect size was significant (OR = 1.25, 95% CI = 1.05 to 1.45, I^2^ = 98.0%, p\<0.001---[Fig 7](#pone.0135947.g007){ref-type="fig"}) indicating that multimorbidity is associated with heightened risk for prescription errors. However, the results showed high levels of heterogeneity, with studies showing both positive and negative associations between multimorbidity and prescription errors.

![Main analysis of the association between prescription error and multimorbidity.](pone.0135947.g007){#pone.0135947.g007}

There was some evidence that the risk for prescription errors varied across types of multimorbidity. Mental-physical multimorbidity was associated with higher risk for prescription errors (OR = 1.98, 95% CI = 1.24 to 2.71, I^2^ = 97.7%, p\<0.001---[Fig 8](#pone.0135947.g008){ref-type="fig"}). In contrast, no association was found between physical multimorbidity and prescription errors (OR = 1.10, 95% CI = 0.90 to 1.30, I^2^ = 97.8%, p\<0.001---[Fig 8](#pone.0135947.g008){ref-type="fig"}).

![Subgroup analysis of the association between prescription error and multimorbidity analysed by different types of multimorbidity.](pone.0135947.g008){#pone.0135947.g008}

### Medication non-adherence {#sec021}

Six studies examined the link between medication non-adherence and multimorbidity. The pooled effect size indicated that multimorbidity had no effect on medication non-adherence (OR = 1.43, 95% CI = 0.67 to 2.18, I^2^ = 99.7%, p\<0.001---[Fig 9](#pone.0135947.g009){ref-type="fig"}).

![Association between medication non-adherence and multimorbidity analysed by different types of multimorbidity.](pone.0135947.g009){#pone.0135947.g009}

The risk for medication non-adherence varied across types of multimorbidity, but the number of studies was small. Studies on mental-physical multimorbidity reported a higher risk of medication non-adherence (OR = 2.16, 95% CI = 1.67 to 2.65, I^2^ = 96.7%, p\<0.001- [Fig 9](#pone.0135947.g009){ref-type="fig"}), whereas the effects of physical multimorbidity on medication non-adherence were non-significant (OR = 0.96, 95% CI = 0.42 to 1.50, I^2^ = 98.9%, p\<0.001- [Fig 9](#pone.0135947.g009){ref-type="fig"}).

### Diagnostic errors {#sec022}

All five studies included in this category measured physical multimorbidity and demonstrated that it was associated with an increased risk of diagnostic errors. The pooled effect size was significant (OR = 1.12, 95% CI = 1.05 to 1.20, I^2^ = 43.6%, p = 0.131---[Fig 10](#pone.0135947.g010){ref-type="fig"}).

![Association between diagnostic error and multimorbidity.](pone.0135947.g010){#pone.0135947.g010}

Sensitivity analyses {#sec023}
--------------------

The main findings for active safety incidents and precursors of safety incidents did not differ when only the 19 studies with sufficient methodological quality scores (meeting 2 out of 3 quality criteria of our protocol) were retained in the analyses. Multimorbidity was associated with significant increases in the risk for active safety incidents (OR = 1.98, 95% CI = 1.40 to 2.57, I^2^ = 91.2%, p\<0.001) and marginal increases in the risk for precursors of safety incidents (OR = 1.17, 95% CI = 1.02 to 1.32, I^2^ = 86.6%, p\<0.001- [Fig 11](#pone.0135947.g011){ref-type="fig"}).

![Sensitivity analysis examining the effects of multimorbidity on active safety incidents and precursors of safety incidents across studies with superior methodological quality scores.](pone.0135947.g011){#pone.0135947.g011}

Publication bias {#sec024}
----------------

The Egger test was significant for active safety incidents indicating that the results in this category might be influenced by publication bias (regression intercept = -7.32, SE = 4.24, p = 0.05- [Fig 12](#pone.0135947.g012){ref-type="fig"}). No funnel plot asymmetry was identified and the Egger test was non-significant for studies examining precursors of safety incidents (regression intercept = -2.09, SE = 2.05, p = 0.312- [Fig 13](#pone.0135947.g013){ref-type="fig"}).

![Funnel plot for studies examining the link between multimorbidity and active safety incidents.](pone.0135947.g012){#pone.0135947.g012}

![Funnel plot for studies examining the link between multimorbidity and precursors of safety incidents.](pone.0135947.g013){#pone.0135947.g013}

Discussion {#sec025}
==========

Summary of the findings {#sec026}
-----------------------

The main aim of this study was to provide the first systematic review of the relationship between multimorbidity and patient safety outcomes. This review found that the relationship between multimorbidity and patient safety outcomes in primary care is complex, with high levels of variability, and may be influenced by different types of safety outcomes and types of multimorbidity. Both mental-physical multimorbidity and physical multimorbidity were associated with higher risk for active safety incidents (such as adverse drug events and medical complications), whereas mental-physical comorbidity (mainly depression) was associated with an increased risk for both active safety incidents and precursors of safety incidents (such as lower quality of care, prescription errors and medication non-adherence). In contrast, physical multimorbidity alone did not increase the risk of precursors of safety incidents, and in some cases was associated with a lower risk for safety failures (e.g. a trend was observed for physical multimorbidity to be associated with better quality of care).

Strengths and limitations {#sec027}
-------------------------

This study has several strengths. This is the first systematic review to provide a comprehensive synthesis of the association between multimorbidity and patient safety outcomes, with a focus on primary care settings, where most of the healthcare for multimorbidity is delivered \[[@pone.0135947.ref012]\]. This review was performed and reported according to PRISMA guidance \[[@pone.0135947.ref033]\]. The searches were designed to be comprehensive and the eligibility criteria were broad, to ensure we incorporated all the evidence in the area.

This study also has important limitations. The review comprises of studies with heterogeneous populations and outcomes. In particular, a wide range of patient safety incidents were included in this review, and even outcomes included under the same subcategory (i.e. precursors) exhibited substantial variation. For example, the 'poor quality of care' category included a variety of incidents including problems in accessing care or receiving inappropriate care, and problems with preventative care. Similarly, different types of multimorbidity were reported across the studies.

We endeavoured to account for the large heterogeneity by applying random effects models, to adjust for between-study variations, and by undertaking subgroup analyses to explore key factors that may account for variation. We only explored the impact of basic sources of heterogeneity (e.g. different types of safety incidents and types of multimorbidity---broadly split into physical/ mental-physical), because multiple subgroup analyses inflate the probability of finding false results \[[@pone.0135947.ref041]\]. However, there are a large number of other factors which could explain the variability in the results of the subgroup analyses. An important factor may be the combinations of conditions which are likely to be included within each of our multimorbidity subgroups. More work may be needed to look at more precise combinations of diseases, or their clustering, which may affect safety outcomes. However, for this to be accomplished, individual studies must clear and consistent about the conditions which are included \[[@pone.0135947.ref121]\].

There is an argument that meta-analysis is inappropriate in the context of high levels of clinical, methodological and statistical heterogeneity \[[@pone.0135947.ref122]\], and the data may be more suited to a narrative synthesis. However, such syntheses are difficult to interpret when many studies are included. We adopted meta-analysis to allow us to compare results across studies, to examine the consistency of effects and explore variables that might account for inconsistency. These results may be at least as important as the pooled estimates we present \[[@pone.0135947.ref123]\].

Grey literature was not included in this review, which may have introduced study selection bias. We excluded grey literature based on evidence suggesting that the quality of research contained in the grey literature is lower and more difficult to appraise compared with research contained in journal articles \[[@pone.0135947.ref124]\]. Visual inspection of the funnel plot and Egger test did not identify evidence of publication bias for studies examining precursors of safety incidents, although publication bias was a possible risk for studies examining active safety incidents.

The large number of studies included in this review did not allow for the involvement of two independent researchers across all data screening and extraction, but reliability tests were performed which indicated high levels of inter-rater agreement. A less comprehensive quality assessment was also undertaken to account for the large number of studies and their variability. Despite this, the assessment of the methodological quality of the studies was designed to allow comparability across multiple different study designs, and were selected based on evidence suggesting that they reflect important quality aspects of observational studies \[[@pone.0135947.ref034]\]. The design of the original studies (mostly cross-sectional and retrospective) obviously imposes limits on our ability to establish causal links between multimorbidity and patient safety and the mechanisms that underpin these links.

Implication for research, policy and practice {#sec028}
---------------------------------------------

Our ability to draw inferences and offer recommendations is significantly hampered by the heterogeneity and inconsistent reporting of outcomes across the studies. Examining the link between multimorbidity and patient safety was usually a secondary aim of the studies. To improve patient safety in multimorbidity we need more primary research which explicitly addresses the relationship between patient safety precursors and incidents in people with multimorbidity. Specifically we need research that examines the mechanism by which multimorbidity affects patient safety. Large prospective studies which can establish temporal relationships are clearly needed to elucidate the relationship between multimorbidity and patient safety, and nested qualitative work may be useful to further illuminate how safety failures come about. Understanding mechanisms is crucial to guide the design of interventions to ameliorate threats to safety in people with multimorbidity. This may need to focus especially on the role of mental health, which the review suggests is an important drivers of safety outcomes.

Additionally, the development of common terminology, measures and reporting is a priority to ensure that future syntheses are not hampered by inconsistent presentation of data \[[@pone.0135947.ref125]\]. A recent systematic review which focused on the effects of comorbidity on benefits of treatment for long-term conditions encountered similar problems in terms of terminology, low methodological quality and lack of studies with a primary focus on the benefits and harms related to the health care of people with multimorbidity \[[@pone.0135947.ref099]\].

The range of safety outcomes reported was limited. For example, the frequency and complexity of healthcare needs and interactions of people with multimorbidity suggests that communication failures may be a key precursor for safety incidents in patients with multimorbidity \[[@pone.0135947.ref126], [@pone.0135947.ref127]\]. However, we found no studies examining the effects of multimorbidity on other types of safety incidents, such as patient-health professional or inter-professional communication or co-ordination of care. Work in these areas should be a priority.

At present there is limited evidence about the impact of interventions in patients with multimorbidity \[[@pone.0135947.ref128]\]. We only identified one trial which examined the effectiveness of a medication review and educational intervention in reducing hospitalisations due to adverse drug events in a high risk elderly population. This study showed that patients with severe multimorbidity (having 5 or more diseases) were significantly more likely to benefit from the intervention compared with patients with low or moderate multimorbidity \[[@pone.0135947.ref129]\]. This finding is encouraging, because it suggests that safety failures are amenable to intervention in patients with high levels of multimorbidity, and that the effects may be greater in those with greater numbers of conditions, a finding which has also been reported in treatment trials \[[@pone.0135947.ref130]\]. Individually-tailored care models which place emphasis on engaging patients with multimorbidity in their care may be a fruitful approach for reducing safety failures \[[@pone.0135947.ref127], [@pone.0135947.ref131], [@pone.0135947.ref132]\].

Conclusion {#sec029}
----------

This is the first systematic review of the association between multimorbidity and patient safety incidents in primary care. Although the patterns of association are complex, a key finding was that patients with multiple long-term conditions and patients with mental-physical comorbidity are at heightened risk for safety failures in some cases. The current evidence on the link between patient safety and multimorbidity is limited in scope and quality. Research is needed to improve the evidence base, to ensure that clinical practice, service organisation and health policy can promote safety in this group of patients.
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